指南与共识乳腺乳腺X线

早期乳腺癌治疗后老年患者的个体化监测乳腺X线摄影:多学科专家组与国际老年肿瘤学会共识声明

Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.
指南 / 共识 · JAMA Oncol · 2021-01-01

该共识由多学科专家组基于文献综述制定,针对75岁及以上早期乳腺癌幸存者,按预期寿命分层给出监测乳腺X线摄影建议:预期寿命不足5年者停止常规摄影,5至10年者可考虑停止,超过10年者继续摄影,并鼓励个体化共享决策。

要点

  • 预期寿命不足5年者,包括高危癌史者,推荐停止常规监测乳腺X线摄影。
  • 预期寿命5至10年者可考虑停止乳腺X线摄影,超过10年者继续摄影。
  • 应继续临床乳腺检查和针对症状的诊断性乳腺X线摄影。

诊断标准与关键数值

  • 预期寿命不足5年:推荐停止常规监测乳腺X线摄影,包括有高危癌史者。
  • 预期寿命5至10年:可考虑停止监测乳腺X线摄影。
  • 预期寿命超过10年:继续监测乳腺X线摄影。
  • 推荐继续临床乳腺检查及针对临床发现和症状的诊断性乳腺X线摄影。

临床应用与阅片要点

  • 对75岁及以上乳腺癌幸存者,应结合预期寿命、同侧及对侧乳腺事件风险及患者偏好进行共享决策。
  • 预期寿命不足5年者推荐停止常规摄影,5至10年者可考虑停止,超过10年者继续摄影。
  • 停止常规摄影者仍应继续临床乳腺检查,出现临床发现或症状时行诊断性乳腺X线摄影。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

IMPORTANCE: There is currently no guidance on how to approach surveillance mammography for older breast cancer survivors, particularly when life expectancy is limited.

OBJECTIVE: To develop expert consensus guidelines that facilitate tailored decision-making for routine surveillance mammography for breast cancer survivors 75 years or older.

EVIDENCE: After a literature review of the risk of ipsilateral and contralateral breast cancer events among breast cancer survivors and the harms and benefits associated with mammography, a multidisciplinary expert panel was convened to develop consensus guidelines on surveillance mammography for breast cancer survivors 75 years or older. Using an iterative consensus-based approach, input from clinician focus groups, and critical review by the International Society for Geriatric Oncology, the guidelines were refined and finalized.

FINDINGS: The literature review established a low risk for ipsilateral and contralateral breast cancer events in most older breast cancer survivors and summarized the benefits and harms associated with mammography. Draft mammography guidelines were iteratively evaluated by the expert panel and clinician focus groups, emphasizing a patient's risk for in-breast cancer events, age, life expectancy, and personal preferences. The final consensus guidelines recommend discontinuation of routine mammography for all breast cancer survivors when life expectancy is less than 5 years, including those with a history of high-risk cancers; consideration to discontinue mammography when life expectancy is 5 to 10 years; and continuation of mammography when life expectancy is more than 10 years. Individualized, shared decision-making is encouraged to optimally tailor recommendations after weighing the benefits and harms associated with surveillance mammography and patient preferences. The panel also recommends ongoing clinical breast examinations and diagnostic mammography to evaluate clinical findings and symptoms, with reassurance for patients that these practices will continue.

CONCLUSIONS AND RELEVANCE: It is anticipated that these expert guidelines will enhance clinical practice by providing a framework for individualized discussions, facilitating shared decision-making regarding surveillance mammography for breast cancer survivors 75 years or older.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Freedman RA, Minami CA, Winer EP, et al. Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. 2021. PMID: 33507222. doi:10.1001/jamaoncol.2020.7582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。